Apogee Therapeutics, Inc. Current Liabilities
Apogee Therapeutics, Inc. (APGE) had Current Liabilities of $37.51 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-10
- 2026-06-30: Liabilities, Current $37.51M.
- 2026-03-31: Liabilities, Current $32.95M.
- 2025-12-31: Liabilities, Current $27.91M.
- 2025-09-30: Liabilities, Current $34.05M.
| Period end | Liabilities, Current |
|---|---|
| 2026-06-30 | $37.51M 10-Q · filed 2026-08-10 |
| 2026-03-31 | $32.95M 10-Q · filed 2026-05-11 |
| 2025-12-31 | $27.91M 10-Q · filed 2026-08-10 |
| 2025-09-30 | $34.05M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $31.55M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $32.96M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $28.56M 10-K · filed 2026-03-02 |
| 2024-09-30 | $32.61M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $24.62M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $21.55M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $20.56M 10-K · filed 2025-03-03 |
| 2023-09-30 | $17.18M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $17.61M 10-Q · filed 2023-08-28 |
| 2022-12-31 | $9.98M 10-K · filed 2024-03-05 |